ABEO
Abeona Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−14.95%
vs ±29.7% implied · ×0.50
shaded = implied · ▲▼ = realized
No thesis.
Abeona Therapeutics Inc.
4.34
−0.22 · −4.83%
post 4.34 0.00%
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Nantahala Capital ManagementNantahala | $38.0M | 14.97% | +2.05% | |
| 2 | BlackRockBlackRockindex-like | $20.7M | 8.15% | +4.91% | |
| 3 | Cable Car CapitalCable Car Capital | $18.6M | 7.31% | 0.00% | |
| 4 | AIGH Capital ManagementAIGH | $18.5M | 7.26% | −3.65% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $13.7M | 5.38% | +2.15% | |
| 6 | Resources Investment AdvisorsResources Investment | $10.2M | 4.02% | new | |
| 7 | AWM InvestmentAWM Investment | $9.2M | 3.61% | +85.04% | |
| 8 | Geode Capital ManagementGeodeindex-like | $7.8M | 3.07% | +4.24% | |
| 9 | Kennedy Capital ManagementKennedy | $7.7M | 3.02% | −1.86% | |
| 10 | Goldman Sachs GroupGoldman Sachs | $7.6M | 2.98% | +8.33% | |
| 11 | State StreetState Streetindex-like | $6.4M | 2.53% | +8.66% | |
| 12 | Propel Bio ManagementPropel Bio | $6.1M | 2.39% | −26.08% | |
| 13 | NAN Fung Trinity (hk)NAN Fung Trinity (hk) | $5.9M | 2.33% | 0.00% | |
| 14 | Diametric CapitalDiametric Capital | $4.7M | 1.84% | +23.47% | |
| 15 | J. GoldmanJ. Goldman | $4.2M | 1.65% | +5.88% | |
| 16 | Silverarc Capital ManagementSilverarc | $3.8M | 1.48% | −5.94% | |
| 17 | Rubric Capital ManagementRubric | $3.8M | 1.48% | new | |
| 18 | Susquehanna International GroupSusquehanna International | $3.7M | 1.47% | −45.58% | |
| 19 | Stonepine Capital ManagementStonepine | $3.4M | 1.36% | −34.17% | |
| 20 | Northern TrustNorthern Trustindex-like | $3.4M | 1.34% | +26.76% | |
| 21 | CitigroupCitigroup | $3.4M | 1.33% | +4.95% | |
| 22 | National Bank of CanadaNational Bank of Canada | $3.1M | 1.22% | 0.00% | |
| 23 | Suvretta Capital ManagementSuvretta | $3.1M | 1.22% | −81.32% | |
| 24 | Knoll Capital ManagementKnoll | $3.0M | 1.18% | 0.00% | |
| 25 | Citadel AdvisorsCitadel | $2.8M | 1.11% | +57.76% |
126 managers report $254.1M of Abeona Therapeutics on form 13F for the quarter ended Jun 30 '26. 22 of them hold 80% of it; Nantahala is largest at 14.97%.
Expected move
No implied move.
No implied move.
No implied move.